Clinical Outcomes of Patients With Diabetic Nephropathy Randomized to Clopidogrel Plus Aspirin Versus Aspirin Alone (A post hoc Analysis of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance [CHARISMA] Trial)

Publication | Closed Access

DOI

124

Citations

References

2009

Year

Arijit Dasgupta, Steven R. Steinhubl, Deepak L. Bhatt, Peter B. Berger, Mingyuan Shao, Koon‐Hou Mak, Keith A.A. Fox, Gilles Montalescot, Michael A. Weber, Steven M. Haffner,

The American Journal of Cardiology

ThrombosisDiabetes ManagementUrologyCardiovascular DiseaseMedicineDiabetesDiabetic Nephropathy RandomizedDiabetic Kidney DiseaseClinical OutcomesDiabetes MellitusPost Hoc AnalysisChronic Kidney DiseaseAtherosclerosisNephrology